Spatial heterogeneity of radiolabeled choline positron emission tomography in tumors of patients with non-small cell lung cancer: first-in-patient evaluation of [<sup>18</sup>F]fluoromethyl-(1,2-<sup>2</sup>H<sub>4</sub>)-choline
Theranostics